Prudential Financial Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 806,764 shares of the healthcare conglomerate's stock after selling 83,345 shares during the quarter. UnitedHealth Group makes up approximately 0.6% of Prudential Financial Inc.'s portfolio, making the stock its 26th largest position. Prudential Financial Inc. owned approximately 0.09% of UnitedHealth Group worth $408,110,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in UNH. ICW Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 18.9% in the fourth quarter. ICW Investment Advisors LLC now owns 2,868 shares of the healthcare conglomerate's stock valued at $1,451,000 after purchasing an additional 455 shares in the last quarter. Jackson Thornton Wealth Management LLC lifted its stake in UnitedHealth Group by 28.0% in the 4th quarter. Jackson Thornton Wealth Management LLC now owns 507 shares of the healthcare conglomerate's stock worth $256,000 after acquiring an additional 111 shares in the last quarter. United Services Automobile Association grew its stake in UnitedHealth Group by 5.1% during the 4th quarter. United Services Automobile Association now owns 71,940 shares of the healthcare conglomerate's stock valued at $36,392,000 after acquiring an additional 3,513 shares in the last quarter. Twin City Private Wealth LLC boosted its holdings in shares of UnitedHealth Group by 2.0% during the fourth quarter. Twin City Private Wealth LLC now owns 1,293 shares of the healthcare conglomerate's stock worth $654,000 after purchasing an additional 25 shares during the period. Finally, Napatree Capital LLC increased its stake in UnitedHealth Group by 16.5% in the 4th quarter. Napatree Capital LLC now owns 629 shares of the healthcare conglomerate's stock valued at $318,000 after buying an additional 89 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
Analyst Upgrades and Downgrades
UNH has been the topic of several research analyst reports. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $629.32.
Get Our Latest Report on UNH
Insider Buying and Selling at UnitedHealth Group
In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.33% of the company's stock.
UnitedHealth Group Stock Performance
Shares of NYSE:UNH traded down $2.92 on Tuesday, hitting $513.58. 3,014,727 shares of the company were exchanged, compared to its average volume of 4,091,387. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $469.78 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. The company's 50 day moving average price is $509.10 and its two-hundred day moving average price is $545.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.64%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.